AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
TuHURA Biosciences Secures $650,000 Through Revolving Credit Facility
PRIVATESep 21, 2026
Amount Raised
$650,000
Round Type
Debt Financing
TampaBiotechnologyHealth CareTherapeutics
Investors
Parkview Holdings One Llc
Description
On September 21, 2026, TuHURA Biosciences, Inc. drew an additional $650,000 from its revolving credit facility with Parkview Holdings One LLC. This funding will be utilized for general corporate purposes. The credit facility can offer up to $50 million and matures on April 21, 2031.
Company Information
Company
TuHURA Biosciences
Location
10500 University Center Drive
Tampa, Florida, United States
About
Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.
Fundz sees it the moment TuHURA Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
TampaBiotechnologyHealth CareTherapeutics